Functional evaluation of various ICAM3 transcript variants in diffuse large B-Cell lymphoma

Leuk Lymphoma. 2022 Dec;63(12):2869-2878. doi: 10.1080/10428194.2022.2092861. Epub 2022 Jul 18.

Abstract

Previous studies have identified several ICAM3 transcript variants and mainly investigated the function of the longest transcript of ICAM3 in various tumor progressions. However, the role of the other ICAM3 transcript variants remains unclear. Herein, we detected the expression of ICAM3 transcript variants 1-4 in DLBCL cells and tumor tissues, disclosed that variants 1, 3, and 4 were expressed in normal B cell lines and 3 DLBCL cell lines except SU-DHL-2 as well as tumor tissues, while variant 2 was not detected. Moreover, we found that ectopic expression of variants 1-4 enhanced cell proliferation by accelerating the cell cycle in SU-DHL2 cells in vitro. In addition, variants 1-4 overexpression showed no effects on SU-DHL2 cell apoptosis. Interestingly, the expression of variants 1, 3, and 4 promoted cell migration and EMT process while variant 2 had no effects. Collectively, the above results displayed the different roles of ICAM3 transcript variants in mediating DLBCL progression.

Keywords: DLBCL; ICAM3; apoptosis; migration; proliferation; transcript variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Intercellular Adhesion Molecule-3* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / pathology

Substances

  • Intercellular Adhesion Molecule-3
  • ICAM3 protein, human